Email updates

Keep up to date with the latest news and content from Nutrition Journal and BioMed Central.

Open Access Highly Accessed Short report

Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers

Jayakanthan Kabeerdoss, R Shobana Devi, R Regina Mary, D Prabhavathi, R Vidya, John Mechenro, NV Mahendri, Srinivasan Pugazhendhi and Balakrishnan S Ramakrishna*

Author affiliations

Department of Gastrointestinal Sciences & Dietary Services, Christian Medical College, Vellore & Department of Zoology, Auxilium College, Vellore, India

For all author emails, please log on.

Citation and License

Nutrition Journal 2011, 10:138  doi:10.1186/1475-2891-10-138

Published: 23 December 2011



Probiotics are used to provide health benefits. The present study tested the effect of a probiotic yoghurt on faecal output of beta-defensin and immunoglobulin A in a group of young healthy women eating a defined diet.


26 women aged 18-21 (median 19) years residing in a hostel were given 200 ml normal yoghurt every day for a week, followed by probiotic yoghurt containing Bifidobacterium lactis Bb12® (109 in 200 ml) for three weeks, followed again by normal yoghurt for four weeks. Stool samples were collected at 0, 4 and 8 weeks and assayed for immunoglobulin A and human beta-defensin-2 by ELISA. All participants tolerated both normal and probiotic yoghurt well. Human beta-defensin-2 levels in faeces were not altered during the course of the study. On the other hand, compared to the basal sample, faecal IgA increased during probiotic feeding (P = 0.0184) and returned to normal after cessation of probiotic yoghurt intake.


Bifidobacterium lactis Bb12® increased secretory IgA output in faeces. This property may explain the ability of probiotics to prevent gastrointestinal and lower respiratory tract infections.

Probiotics; innate immunity; health promotion; mucosal defences